Exponent Inc. (EXPO)
Exponent Inc. (EXPO) Stock Price, Analysis & Data
No hay datos disponibles
| Precio de compra | 48.28 |
| Capitalización de mercado | 3.24B |
| Ingresos (TTM) | 567.13M |
| Beneficio neto (TTM) | 111.77M |
| Beta | 0.68 |
| EPS (TTM) | 2.23 |
| Ratio PER (TTM) | 30.59 |
| Adelante PE | 24.01 |
| P/B (TTM) | 11.23 |
| P/S (TTM) | 5.72 |
| Earnings Date | Oct 29, 2026 |
| Precio de venta | 87.46 |
| Volumen | 385,063 |
| Volumen medio (20D) | 585,587 |
| Abierto | 68.38 |
| Anterior Cerrar | 67.64 |
| Rango del día | 66.78 - 68.55 |
| Rango de 52 semanas | 51.91 - 81.95 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | $1.23 (1.82%) |
| Fecha ex dividendo | 4 sept 2026 |
Acerca de EXPO
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer sci...
Desempeño financiero
En 2025, los ingresos de Exponent fueron 582.01M, un aumento de 4.21% en comparación con 558.51M del año anterior. Las ganancias fueron 106.01M, una disminución de -2.75%.
Estados financierosSorpresa de resultados
Los analistas proyectan ingresos de ... Actualizar
1 semana hace · Simply Wall St.
Exponent (EXPO) Could Be 17% Undervalued On Strong Results And Higher GuidanceExponent (EXPO) drew fresh attention after reporting second quarter 2026 results with higher sales, revenue, net income and earnings per share compared with a year earlier, alongside raised full year ...
